1M6MYTD1Å5ÅMAKS.
Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 75,22 € (+11,85 %). Medianen er 78,35 € (+16,51 %).
| Køb |
11 |
| Behold |
0 |
| Sælg |
0 |
Nyheder Til nyhedsfeedet
Kiniksa Pharmaceuticals International names Ross Moat COO and Eben Tessari chief strategy officer
Kiniksa Pharmaceuticals International’s board has appointed Ross Moat as chief operating officer effective Friday; Moat will also remain responsible for commercial activities. Eben Tessari was named chief strategy officer and will continue to lead strategy, business development and technical operations as well as the company’s AI initiatives. Both appointments involve no changes to compensation arrangements; Kiniksa is headquartered in London and trades on Nasdaq under the ticker KNSA. » Mere på de.investing.com
Virksomhedstal
| (EUR) | juni 2026 | |
|---|---|---|
| Omsætning | 213,44 mio. | 60,45 % |
| Bruttofortjeneste | 115,62 mio. | 58,90 % |
| Nettoresultat | 22,28 mio. | 47,29 % |
| EBITDA | 24,24 mio. | 22,97 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 5,12 mia. € |
Antal aktier | 76,21 mio. |
Højeste/laveste i 52 uger | 72,21 € - 30,64 € |
| Udbytte | Nej |
Beta | 0,09 |
P/E (PE Ratio) | 72,19 |
PEG (PEG Ratio) | 0,04 |
K/I (PB Ratio) | 9,16 |
P/S (PS Ratio) | 7,00 |
Virksomhedsprofil
| Navn | Kiniksa Pharmaceuticals International PLC Class A |
| CEO | Sanj K. Patel |
| Hjemsted | London,
gl Storbritannien |
| Websted | |
| Sektor | Materialer |
| Branche | Kemikalier |
| Medarbejdere | 366 |
